Market Cap 1.35B
Revenue (ttm) 233.18M
Net Income (ttm) -321.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -137.90%
Debt to Equity Ratio 0.00
Volume 1,097,400
Avg Vol 1,813,412
Day's Range N/A - N/A
Shares Out 88.81M
Stochastic %K 12%
Beta 0.75
Analysts Strong Sell
Price Target $34.78

Latest News on TVTX

Travere Therapeutics to Present at Upcoming Investor Conferences

Nov 25, 2024, 4:30 PM EST - 6 months ago

Travere Therapeutics to Present at Upcoming Investor Conferences